Leukemia Inhibitory Factor: An Important Cytokine in Pathologies and Cancer

por Jorgensen, Megan M., de la Puente, Pilar
Publicado 2022

Mimicking tumor hypoxia and tumor-immune interactions employing three-dimensional in vitro models

por Bhattacharya, Somshuvra, Calar, Kristin, de la Puente, Pilar
Publicado 2020

The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy

por Muz, Barbara, de la Puente, Pilar, Azab, Feda, Azab, Abdel Kareem
Publicado 2015

Human Plasma-Derived 3D Cultures Model Breast Cancer Treatment Responses and Predict Clinically Effective Drug Treatment Concentrations

por Calar, Kristin, Plesselova, Simona, Bhattacharya, Somshuvra, Jorgensen, Megan, de la Puente, Pilar
Publicado 2020

Bioengineering the Oxygen-Deprived Tumor Microenvironment Within a Three-Dimensional Platform for Studying Tumor-Immune Interactions

por Bhattacharya, Somshuvra, Calar, Kristin, Evans, Claire, Petrasko, Mark, de la Puente, Pilar
Publicado 2020

Molecularly Targeted Therapies in Multiple Myeloma

por de la Puente, Pilar, Muz, Barbara, Azab, Feda, Luderer, Micah, Azab, Abdel Kareem
Publicado 2014

Selinexor Overcomes Hypoxia-Induced Drug Resistance in Multiple Myeloma

por Muz, Barbara, Azab, Feda, de la Puente, Pilar, Landesman, Yosef, Azab, Abdel Kareem
Publicado 2017

Inhibition of P-Selectin and PSGL-1 Using Humanized Monoclonal Antibodies Increases the Sensitivity of Multiple Myeloma Cells to Bortezomib

por Muz, Barbara, Azab, Feda, de la Puente, Pilar, Rollins, Scott, Alvarez, Richard, Kawar, Ziad, Azab, Abdel Kareem
Publicado 2015

A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myeloma

por Alhallak, Kinan, Jeske, Amanda, de la Puente, Pilar, Sun, Jennifer, Fiala, Mark, Azab, Feda, Muz, Barbara, Sahin, Ilyas, Vij, Ravi, DiPersio, John F., Azab, Abdel Kareem
Publicado 2021

Reduction of Metastasis via Epigenetic Modulation in a Murine Model of Metastatic Triple Negative Breast Cancer (TNBC)

por Zylla, Jessica L. S., Hoffman, Mariah M., Plesselova, Simona, Bhattacharya, Somshuvra, Calar, Kristin, Afeworki, Yohannes, de la Puente, Pilar, Gnimpieba, Etienne Z., Miskimins, W. Keith, Messerli, Shanta M.
Publicado 2022

Analysis of Dual Class I Histone Deacetylase and Lysine Demethylase Inhibitor Domatinostat (4SC-202) on Growth and Cellular and Genomic Landscape of Atypical Teratoid/Rhabdoid

por Hoffman, Mariah M., Zylla, Jessica S., Bhattacharya, Somshuvra, Calar, Kristin, Hartman, Timothy W., Bhardwaj, Ratan D., Miskimins, W. Keith, de la Puente, Pilar, Gnimpieba, Etienne Z., Messerli, Shanta M.
Publicado 2020

The WNK1–ERK5 route plays a pathophysiological role in ovarian cancer and limits therapeutic efficacy of trametinib

por Sánchez‐Fdez, Adrián, Matilla‐Almazán, Sofía, Montero, Juan Carlos, Del Carmen, Sofía, Abad, Mar, García‐Alonso, Sara, Bhattacharya, Somshuvra, Calar, Kristin, de la Puente, Pilar, Ocaña, Alberto, Pandiella, Atanasio, Esparís‐Ogando, Azucena
Publicado 2023

Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma

por Federico, Cinzia, Alhallak, Kinan, Sun, Jennifer, Duncan, Kathleen, Azab, Feda, Sudlow, Gail P., de la Puente, Pilar, Muz, Barbara, Kapoor, Vaishali, Zhang, Luna, Yuan, Fangzheng, Markovic, Matea, Kotsybar, Joseph, Wasden, Katherine, Guenthner, Nicole, Gurley, Shannon, King, Justin, Kohnen, Daniel, Salama, Noha N., Thotala, Dinesh, Hallahan, Dennis E., Vij, Ravi, DiPersio, John F., Achilefu, Samuel, Azab, Abdel Kareem
Publicado 2020